Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BALCHEM CORP

Get SEC filing alerts via email and in your feed for BALCHEM CORP

BCPC

BALCHEM CORP

About BALCHEM CORP

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products across Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products segments. Its offerings include human-grade choline nutrients, mineral amino acid chelates, MSM, vitamin K2, microencapsulated animal nutrition products, and performance gases like ethylene oxide for medical sterilization. Serving global food, pharmaceutical, animal health, and industrial markets, Balchem leverages proprietary technologies and scientific expertise to deliver high-quality, value-added solutions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from BALCHEM CORP

1
1
BALCHEM CORP Balchem Corporation Reports 8.1% Net Sales Increase to $270.7 Million in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
BALCHEM CORP Balchem Corporation Reports 8.8% Revenue Growth to $1,037.2 Million for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
BALCHEM CORP Balchem Corporation Reports 11.5% Revenue Growth in Q3 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
BALCHEM CORP Balchem Corporation Reports 9.1% Revenue Growth in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
BALCHEM CORP Balchem Corporation Reports 4.5% Revenue Growth to $250.5 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BALCHEM CORP Balchem Corporation Reports 3.4% Net Sales Increase to $953.7 Million in Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
BALCHEM CORP Balchem Corporation Reports Strong Q3 and Nine-Month Results with Increased Net Sales, Gross Margin, and Net Earnings

Via official filing (AI summary) | over 1 year ago | 0 comments